BAY 59-3074
# BAY 59-3074

BAY 59-3074 is a drug which is a cannabinoid receptor partial agonist developed by Bayer AG. It has analgesic effects and is used in scientific research. It is orally active in animals, and has modest affinity for both $CB_1$ and $CB_2$ receptors, with $K_i$ values of 48.3nM at $CB_1$ and 45.5nM at $CB_2.$

